Lack of Federal Regulation of Medical Cannabis Raises Risks

By Michael J. Gaunt

MEDICAL CANNABIS DIFFERS FROM THE STREET PRODUCT in that the plant must be reliably grown and handled according to good manufacturing practices. This allows growers to assay and establish the products’ contents with the intent to pass along that information to dispensaries and patients.

However, lack of federal regulation has led to significant differences among state programs, yielding a wide variety of cannabis formulations, products, and strain names, and lack of consistency in state labeling requirements has given rise to practices that risk patient safety. Thus, it is difficult for dispensaries to provide patients with clearly labeled products, a critical component for reproducible and safe effects.

To read more:

Leave a Reply

Your email address will not be published. Required fields are marked *